Community Outreach and Engagement COE
社区外展和参与COE
基本信息
- 批准号:10671713
- 负责人:
- 金额:$ 22.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-11 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvocateAffectAntineoplastic AgentsAreaAutomobile DrivingBasic Cancer ResearchBiometryBlack raceBudgetsCancer BiologyCancer BurdenCancer CenterCancer ControlCancer Control ResearchCancer PatientCatchment AreaChargeClinicalClinical TrialsCollaborationsCollectionCommunicationCommunitiesCommunity OutreachCountyDataDatabasesDevelopmentDissemination and ImplementationEducationEvaluationEvidence based interventionFosteringFundingFutureGoalsGrantHealth PolicyHematologic NeoplasmsHispanicHospitalsIncidenceIndividualInformation SystemsInfrastructureInstitutionInvestigational TherapiesKansasKnowledgeLaboratoriesLeadershipLogicMalignant Childhood NeoplasmMalignant NeoplasmsMalignant neoplasm of gastrointestinal tractMalignant neoplasm of prostateMissionMissouriModelingMonitorNCI Center for Cancer ResearchObesityPatientsPlayPoliciesPopulationPreventionPrimary CareProviderRadiation OncologistRecommendationResearchResearch ActivityResearch PersonnelResearch SupportRisk BehaviorsRoleRuralRural PopulationScienceScientistScreening for cancerTechnologyTherapeutic AgentsTherapeutic ResearchTobaccoTobacco-Related CarcinomaTrainingUniversitiesVisionWorkanticancer researchcancer carecancer health disparitycancer preventioncancer therapycare deliverycommunity engaged researchcommunity engagementcommunity organizationscomparative effectivenessdata warehousedrug discoveryexperiencehealth equityimprovedmalignant breast neoplasmmembermobile health clinicmortalityneoplasm registrynovel therapeuticsoutreachpopulation basedprogramspublic educationrural cancer carerural patientsscreeningtrend
项目摘要
COMMUNITY OUTREACH AND ENGAGEMENT: ABSTRACT
Community Outreach and Engagement (COE) efforts are central to The University of Kansas Cancer Center
(KUCC) achieving its mission to reduce the cancer burden in our catchment area (CA). COE is led by Ronald
Chen, MD, MPH, Associate Director for Health Equity, and guided by the CA Steering Committee which
includes KUCC leaders and community stakeholders. Hope Krebill, MSW, BSN, RN, serves as Assistant
Director for Outreach and Executive Director of the Masonic Cancer Alliance (MCA), which implements COE
activities throughout the CA. The KUCC CA consists of the state of Kansas and 18 counties in western Missouri,
a total of 123 counties and 4.5M population; 78% of counties and 25% of population are rural. Aim 1: Identify,
monitor, and evaluate the cancer burden and needs, and KUCC impact, in the CA. KUCC has developed
a database called OPTIK (Organize and Prioritize Trends to Inform KUCC), which is used to monitor cancer
incidence, mortality, screening, and risk behaviors in the CA. These data are reviewed by the KUCC
Community Advisory Board and the CA Steering Committee. KUCC selected priorities with the CA Steering
Committee and Community Advisory Board input, which are: obesity, tobacco-related cancers, prostate
cancer, breast cancer, gastrointestinal cancers, and hematological cancers. There is an additional focus on
rural patients given the make-up of our CA. Aim 2: Engage stakeholders to stimulate cancer research and
control activities. COE works with an extensive infrastructure creating bi-directional communication between
KUCC and diverse stakeholders including patients, clinical providers, and hospitals throughout the CA, which
helps KUCC set priorities for cancer research and control activities, and also collaborate in these activities to
affect individuals throughout the catchment area. Aim 3: Catalyze research that addresses high-priority
cancers and issues specifically relevant to the CA and as guided by community stakeholders to
improve health equity. COE plays a critical role in stimulating and supporting KUCC research in four
important ways: 1) By facilitating bi-directional communication with community members to define KUCC
priority areas and communicating these priorities to KUCC program leaders and members in order to focus
research activities toward these priorities; 2) by fostering collaborations between KUCC researchers and
community collaborators, and training researchers on community-engaged research; 3) by driving continued
efforts for KUCC to focus on the unique needs of rural cancer patients in the CA; and 4) by creating and
operationally supporting an infrastructure throughout the CA that can be leveraged for research. Aim 4: Drive,
disseminate and implement cancer control activities and policies to reduce cancer burden in the CA in
collaboration with community stakeholders. These activities include cancer screenings, implementation of
evidence-based interventions, public education, supporting community cancer centers, and influencing health
policy. A detailed evaluation framework and future directions will enhance efforts related to these specific aims.
社区外展和参与:摘要
社区外展和参与(COE)工作是堪萨斯大学癌症中心的核心
(KUCC)实现其使命,以减少癌症负担在我们的集水区(CA)。COE由罗纳德领导
Chen,MD,MPH,健康公平副主任,并由CA指导委员会指导,
包括KUCC领导人和社区利益相关者。希望Krebill,MSW,BSN,RN,担任助理
负责实施特遣队所属装备的共济会癌症联盟外联主任兼执行主任
整个CA的活动。KUCC CA由堪萨斯州和密苏里州西部的18个县组成,
全国共有123个县,450万人口; 78%的县和25%的人口是农村。目标1:确定,
监测和评估癌症负担和需求,以及KUCC的影响,在CA。KUCC开发了
一个名为OPTIK(Organize and Prioritize Trends to Inform KUCC)的数据库,用于监测癌症
CA的发病率、死亡率、筛查和危险行为。这些数据由KUCC审查
社区咨询委员会和CA指导委员会。KUCC选择CA指导的优先事项
委员会和社区咨询委员会的投入,其中包括:肥胖,烟草相关的癌症,前列腺
癌症、乳腺癌、胃肠癌和血液癌症。还有一个重点是
农村病人的情况。目标2:让利益相关者参与促进癌症研究,
控制活动。COE与广泛的基础架构配合使用,
KUCC和不同的利益相关者,包括患者,临床提供者和整个CA的医院,
帮助KUCC确定癌症研究和控制活动的优先事项,并在这些活动中进行合作,
影响整个集水区的个人。目标3:促进针对高度优先事项的研究
癌症和与CA特别相关的问题,并在社区利益相关者的指导下,
改善卫生公平性。COE在激励和支持KUCC研究方面发挥着关键作用,
重要途径:1)通过与社区成员的双向沟通,定义KUCC
优先领域,并将这些优先事项传达给KUCC项目负责人和成员,
2)通过促进KUCC研究人员之间的合作,
社区合作者,并培训社区参与研究的研究人员; 3)继续推动
KUCC努力关注CA农村癌症患者的独特需求; 4)通过创建和
在整个CA中为可用于研究的基础设施提供运营支持。目标4:开车,
传播和推行癌症控制活动和政策,以减轻癌症在加州的负担,
与社区利益相关者合作。这些活动包括癌症筛查、
循证干预、公共教育、支持社区癌症中心和影响健康
政策详细的评价框架和今后的方向将加强与这些具体目标有关的努力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ronald Chen其他文献
Ronald Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ronald Chen', 18)}}的其他基金
University of Kansas Cancer Center Paul Calabresi K12 Career Development Award for Clinical Oncology
堪萨斯大学癌症中心 Paul Calabresi K12 临床肿瘤学职业发展奖
- 批准号:
10647369 - 财政年份:2023
- 资助金额:
$ 22.3万 - 项目类别:
NC ProCESS: a Stakeholder-Driven, Population-Based Prospective Cohort Study
NC ProCESS:利益相关者驱动、基于人群的前瞻性队列研究
- 批准号:
8761397 - 财政年份:2014
- 资助金额:
$ 22.3万 - 项目类别:
SCH: Proactive Health Monitoring Using Individualized Analysis of Tissue Elastic*
SCH:使用组织弹性个体化分析进行主动健康监测*
- 批准号:
8934115 - 财政年份:2014
- 资助金额:
$ 22.3万 - 项目类别:
SCH: Proactive Health Monitoring Using Individualized Analysis of Tissue Elastic*
SCH:使用组织弹性个体化分析进行主动健康监测*
- 批准号:
8788148 - 财政年份:2014
- 资助金额:
$ 22.3万 - 项目类别:
PROMIS Validation in Prospective Population-based Prostate Cancer Research Study
基于人群的前瞻性前列腺癌研究中的 PROMIS 验证
- 批准号:
8549188 - 财政年份:2012
- 资助金额:
$ 22.3万 - 项目类别:
PROMIS Validation in Prospective Population-based Prostate Cancer Research Study
基于人群的前瞻性前列腺癌研究中的 PROMIS 验证
- 批准号:
8895759 - 财政年份:2012
- 资助金额:
$ 22.3万 - 项目类别:
PROMIS Validation in Prospective Population-based Prostate Cancer Research Study
基于人群的前瞻性前列腺癌研究中的 PROMIS 验证
- 批准号:
8458339 - 财政年份:2012
- 资助金额:
$ 22.3万 - 项目类别:
PROMIS Validation in Prospective Population-based Prostate Cancer Research Study
基于人群的前瞻性前列腺癌研究中的 PROMIS 验证
- 批准号:
8700355 - 财政年份:2012
- 资助金额:
$ 22.3万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 22.3万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 22.3万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 22.3万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 22.3万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 22.3万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 22.3万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 22.3万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 22.3万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 22.3万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 22.3万 - 项目类别:














{{item.name}}会员




